Neuronetics to Report Second Quarter 2020 Financial and Operating Results and Host Conference Call
21 juil. 2020 08h00 HE
|
Neuronetics
MALVERN, Pa., July 21, 2020 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical technology company focused on designing, developing and marketing products that improve...
Neuronetics to Present at the William Blair 40th Annual Growth Stock Conference
04 juin 2020 16h30 HE
|
Neuronetics
MALVERN, Pa., June 04, 2020 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ:STIM), a commercial stage medical technology company focused on designing, developing and marketing products that improve...
Neuronetics Recognizes Critical Health Professionals During Mental Health Awareness Month
07 mai 2020 08h00 HE
|
Neuronetics
MALVERN, Pa., May 07, 2020 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical technology company focused on designing, developing and marketing products that improve...
Neuronetics to Report First Quarter 2020 Financial and Operating Results and Host Conference Call
21 avr. 2020 08h00 HE
|
Neuronetics
MALVERN, Pa., April 21, 2020 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical technology company focused on designing, developing and marketing products that improve...
Neuronetics Recognized as 2020 Top Neurology Device Provider
30 mars 2020 07h30 HE
|
Neuronetics
Company acknowledged on Top 10 List by MedTech Outlook Magazine MALVERN, Pa., March 30, 2020 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical technology company...
Neuronetics® Hits Major Milestones with More Than 2.5 Million Treatments and 1,000 Installations of Its NeuroStar® Advanced Therapy System
16 mars 2020 07h30 HE
|
Neuronetics
MALVERN, Pa., March 16, 2020 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical technology company focused on designing, developing and marketing products that improve...
FDA Grants NeuroStar® Advanced Therapy System Breakthrough Device Designation to Treat Bipolar Depression
06 mars 2020 07h30 HE
|
Neuronetics
MALVERN, Pa., March 06, 2020 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ:STIM), a commercial stage medical technology company focused on designing, developing and marketing products that improve...
Neuronetics Reports Fourth Quarter and Full Year 2019 Financial and Operating Results
03 mars 2020 06h00 HE
|
Neuronetics
MALVERN, Pa., March 03, 2020 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical technology company focused on designing, developing and marketing products that improve...
Neuronetics to Report Fourth Quarter and Fiscal Year 2019 Financial and Operating Results and Host Conference Call
18 févr. 2020 08h00 HE
|
Neuronetics
MALVERN, Pa., Feb. 18, 2020 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical technology company focused on designing, developing and marketing products that improve...
Neuronetics Appoints Andrew Macan As Senior Vice President, General Counsel, Chief Compliance Officer and Corporate Secretary
21 janv. 2020 07h30 HE
|
Neuronetics
MALVERN, Pa., Jan. 21, 2020 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ:STIM), a commercial stage medical technology company focused on designing, developing and marketing products that improve...